InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（5 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Lindstrom Richard l Md, 董事. Director active across 5 companies, notably Harrow Health, INC.. In total, 16 disclosures have been published. Breakdown: 2 buys · 5 sells. Total volume traded: €1.3m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 20 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lindstrom Richard l Md
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
60,229 股@ US$7.66100.0% 占其流量Common StockSEC:0001104659-26-019256:0
标准退出：2026年5月21日 (T+90)
14,000 股0Common StockSEC:0001104659-25-059388:0
7,374 股0Common StockSEC:0000950170-25-078369:0
10,000 股@ US$6.9613.5% 占其流量Common StockSEC:0001104659-25-047435:0
标准退出：2025年8月6日 (T+90)
18,939 股@ US$8.8033.3% 占其流量Common StockSEC:0001104659-24-083104:0
22,000 股0Common StockSEC:0000950170-24-057107:0
12,000 股0Common StockSEC:0001104659-23-072402:0
9,288 股0Common StockSEC:0000899243-23-014072:0
40,000 股@ US$12.6278.3% 占其流量Common StockSEC:0001493152-22-027463:0
8,933 股0Common StockSEC:0001104659-22-073148:0
4,285 股0Common StockSEC:0000899243-22-020012:0
9,469 股@ US$1.220.0006% mcap4.5% 占其流量Common StockSEC:0001104659-22-061322:0
3,900 股@ US$10.0414.5% 占其流量Common StockSEC:0001493152-21-023910:0
14,160 股@ US$9.0947.3% 占其流量Common StockSEC:0001493152-21-023036:0
10,000 股@ US$14.3034.0% 占其流量Common StockSEC:0001104659-21-070642:0
10,000 股@ US$10.7538.2% 占其流量Common StockSEC:0001493152-21-012566:0
16 条申报中的 16 条
About Lindstrom Richard l Md
LINDSTROM RICHARD L MD is Administrateur and has filed 16 filings. In the sampled recent filings we hold, buys amount to EUR 454012 and sells to EUR 860702, with transactions ranging from 2021-05-21 to 2026-02-24. He is listed as a director at Ocular Therapeutix, INC, LENSAR, Inc., Harrow Health, INC., OCULAR THERAPEUTIX, INC and HARROW HEALTH, INC., and the modal transaction nature is Attribution.
